477 related articles for article (PubMed ID: 10908610)
21. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
van Groen T; Kadish I
Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
[TBL] [Abstract][Full Text] [Related]
22. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
23. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
24. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
[TBL] [Abstract][Full Text] [Related]
25. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
26. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice.
Nikolic WV; Hou H; Town T; Zhu Y; Giunta B; Sanberg CD; Zeng J; Luo D; Ehrhart J; Mori T; Sanberg PR; Tan J
Stem Cells Dev; 2008 Jun; 17(3):423-39. PubMed ID: 18366296
[TBL] [Abstract][Full Text] [Related]
27. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
[TBL] [Abstract][Full Text] [Related]
28. Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.
Di Meco A; Kemal S; Popovic J; Chandra S; Sadleir K; Vassar R
Curr Alzheimer Res; 2022; 19(4):317-329. PubMed ID: 35579170
[TBL] [Abstract][Full Text] [Related]
29. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
30. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease.
Wilkinson BL; Cramer PE; Varvel NH; Reed-Geaghan E; Jiang Q; Szabo A; Herrup K; Lamb BT; Landreth GE
Neurobiol Aging; 2012 Jan; 33(1):197.e21-32. PubMed ID: 20696495
[TBL] [Abstract][Full Text] [Related]
31. Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease.
Quinn J; Montine T; Morrow J; Woodward WR; Kulhanek D; Eckenstein F
J Neuroimmunol; 2003 Apr; 137(1-2):32-41. PubMed ID: 12667645
[TBL] [Abstract][Full Text] [Related]
32. A new approach for Alzheimer's disease treatment through P-gp regulation via ibuprofen.
Zhang C; Qin H; Zheng R; Wang Y; Yan T; Huan F; Han Y; Zhu W; Zhang L
Pathol Res Pract; 2018 Nov; 214(11):1765-1771. PubMed ID: 30139557
[TBL] [Abstract][Full Text] [Related]
33. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
[TBL] [Abstract][Full Text] [Related]
34. ApoE facilitates the microglial response to amyloid plaque pathology.
Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
[TBL] [Abstract][Full Text] [Related]
35. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
36. Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen Presentation.
Gericke C; Mallone A; Engelhardt B; Nitsch RM; Ferretti MT
Front Immunol; 2020; 11():1029. PubMed ID: 32582162
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
[TBL] [Abstract][Full Text] [Related]
38. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
39. CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.
Daschil N; Obermair GJ; Flucher BE; Stefanova N; Hutter-Paier B; Windisch M; Humpel C; Marksteiner J
J Alzheimers Dis; 2013; 37(2):439-51. PubMed ID: 23948887
[TBL] [Abstract][Full Text] [Related]
40. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
